AVNS
Avanos Medical Inc
25.00$
+0.0%
vs. previous close
Closing price · As of: Jul 24, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 27.1% | 33.8% | 28.6% | 52.9% | 38.9% | 29.9% | 27.9% | 26.7% | 34.9% | 28.8% | 34.1% | 33.1% | |
| 5.9% | 6.5% | 5.5% | 10.0% | 21.0% | 11.4% | 6.7% | 7.4% | 7.1% | 5.2% | 9.3% | 8.4% | |
| 5.9% | 6.5% | 5.5% | 10.0% | 21.0% | 11.4% | 6.7% | 7.4% | 7.1% | 5.2% | 9.3% | 8.4% | |
| 9.3% | 11.2% | 9.2% | 9.2% | 8.2% | 9.1% | 10.0% | 8.2% | 9.4% | 8.4% | 11.5% | 9.7% | |
| 11.2% | 15.2% | 13.2% | 4.1% | 6.6% | 8.1% | 10.1% | 9.9% | 7.4% | 9.6% | 12.0% | 13.8% | |
| 11.0% | 14.0% | 12.6% | 5.0% | 8.4% | 10.3% | 10.5% | 10.5% | 9.2% | – | – | – | |
| 56.4% | 47.3% | 49.7% | 34.8% | 42.7% | 44.5% | 48.0% | 50.0% | 42.5% | 47.0% | 39.5% | 36.8% | |
| 4.3% | 4.1% | 8.2% | 6.8% | 9.2% | 10.2% | 9.4% | 8.8% | 13.1% | 14.2% | 9.7% | 11.0% | |
| 41.0% | 47.2% | 46.8% | 44.7% | 29.2% | 29.7% | 24.9% | 20.8% | 27.7% | 26.9% | 28.2% | 27.5% | |
| 14.1% | 15.8% | 15.7% | 17.8% | 14.4% | 11.8% | 9.9% | 8.7% | 10.7% | 13.9% | 14.4% | 15.4% | |
| 0.2% | 28.9% | 27.9% | 1.8% | – | 0.8% | 0.9% | 0.9% | 1.0% | 1.3% | 1.8% | 1.7% | |
| 6.7% | 8.2% | 8.4% | 7.8% | 9.3% | 4.6% | 4.0% | 3.5% | 3.8% | 3.3% | 4.7% | 5.2% | |
| 25.0% | 28.9% | 27.9% | 24.6% | 13.5% | 13.8% | 10.8% | 8.1% | 12.7% | 9.4% | 10.9% | 8.4% | |
| 59.0% | 52.8% | 53.2% | 55.3% | 70.8% | 70.3% | 75.1% | 79.2% | 72.3% | 73.1% | 71.8% | 72.5% | |
| 0.3% | -20.9% | -18.3% | -13.7% | -13.2% | -16.0% | -18.9% | -18.9% | -14.2% | -18.6% | -61.3% | -72.6% | |
| 1.8% | 2.3% | 2.3% | 2.1% | 2.6% | 2.6% | 2.9% | 3.0% | 2.6% | 2.8% | 4.0% | 4.3% |
Data as of: July 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.